论文部分内容阅读
目的:观察依达拉奉、奥扎格雷钠、疏血通联合用药治疗急性脑梗死临床临床效果。方法:随机将急性脑梗死260例患者分为治疗组130例和对照组130例,0.9%氯化钠注射液100ml依达拉奉30mg2次/d静点,0.9%氯化钠注射液250ml奥扎格雷钠80mg2次/d静点,同时予0.9%氯化钠注射液250ml疏血通8ml静点1次/d。对照组采用0.9%氯化钠注射液100ml依达拉奉30mg2次/d静点,0.9%氯化钠注射液250ml奥扎格雷钠80mg2次/d静点,同时予0.9%氯化钠注射液250ml血栓通0.45g1次/d。2组治疗14天观察效果。2组其他治疗如降压、降糖、降脂等均相同。结果:治疗组神经功能有效改善,总有效率98.5%,对照组神经功能有效改善,总有效率88.5%。结论:观察依达拉奉、奥扎格雷钠、疏血通联合用药治疗急性脑梗死疗效显著。
Objective: To observe the clinical effect of edaravone, ozagrel and combination of Shuxuetong in the treatment of acute cerebral infarction. Methods: 260 patients with acute cerebral infarction were randomly divided into treatment group 130 cases and control group 130 cases, 0.9% sodium chloride injection 100ml edaravone 30mg2 times / d static point, 0.9% sodium chloride injection 250ml Austria Zagre sodium 80mg2 times / d static point, at the same time to 0.9% sodium chloride injection 250ml Shuqintong 8ml static point 1 times / d. The control group with 0.9% sodium chloride injection 100ml edaravone 30mg2 times / d static point, 0.9% sodium chloride injection 250ml ozagrel sodium 80mg2 times / d static point, while 0.9% sodium chloride injection 250ml thrombosis 0.45g1 times / d. Two groups of 14 days to observe the effect. 2 other treatment such as blood pressure, hypoglycemic, lipid-lowering, etc. are the same. Results: The neurological function of the treatment group was effectively improved, with a total effective rate of 98.5%. The neurological function of the control group was effectively improved with a total effective rate of 88.5%. Conclusion: The observation of edaravone, ozagrel sodium, and Shuxuetong combined treatment of acute cerebral infarction significant effect.